BGI
AURA icon

B Group Inc’s Aura Biosciences AURA Stock Holding History

B Group Inc’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.43M Buy
764,243
+166,667
+28% +$1.19M 2.55% 14
2026
Q1 		$4M Buy
597,576
+25,000
+4% +$143K 2.96% 13
2025
Q4 		$3.12M Hold
572,576
– – 2.3% 12
2025
Q3 		$3.54M Hold
572,576
– – 2.6% 11
2025
Q2 		$3.58M Buy
572,576
+100,000
+21% +$585K 2.76% 10
2025
Q1 		$2.77M Hold
472,576
– – 2.37% 7
2024
Q4 		$3.88M Buy
+472,576
New +$4.45M 2.37% 8

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

B Group Inc's AURA Position: Q2 2026 in Review

B Group Inc increased its Aura Biosciences (AURA) stake by 28% in Q2 2026, buying an estimated $1.19M and bringing the position to 764,243 shares worth $5.43M. The position accounts for 2.55% of the portfolio, ranked #14.

B Group Inc first reported a position in AURA in Q4 2024 and has held it in 7 quarters since. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • B Group Inc held 764,243 shares of Aura Biosciences worth $5.43M as of Q2 2026.
  • B Group Inc bought 166,667 Aura Biosciences shares in Q2 2026, an estimated $1.19M.
  • Aura Biosciences made up 2.55% of B Group Inc's portfolio in Q2 2026, its #14 holding.
  • B Group Inc first reported a position in Aura Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on B Group Inc's 13F filing for Q2 2026, filed 14 Aug 2026.